Abstract
The primary goals of neoadjuvant hormonal therapy (NHT) in prostate cancer (PCa) are to reduce the size of the tumor, lower positive surgical margin r......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
